“…DA, NE, and ACh antagonists degrade practice-dependent plasticity in healthy subjects (Sawaki et al, , 2003Meintzschel and Ziemann, 2006), and retrospective studies strongly suggest that these NMDs are also detrimental in sensorimotor recovery after cerebral stroke (Goldstein et al, 1990;Goldstein, 1995). Conversely, DA, NE, and ACh agonists facilitate practice-dependent plasticity in healthy subjects Flöel et al, 2005a;Meintzschel and Ziemann, 2006) and may be beneficial in stroke rehabilitation (Crisostomo et al, 1988;Walker-Batson et al, 1995;Grade et al, 1998;Scheidtmann et al, 2001;Berthier et al, 2003;Flöel et al, 2005b;Zittel et al, 2007) although this evidence is not undisputed (for review, see Rösser and Flöel, 2008;Berends et al, 2009). The congruence of suppressive effects of NMDs on PASinduced LTP-like plasticity and practice-dependent plasticity suggests that PAS-induced LTP-like plasticity may serve as a biological marker for unfavorable drug effects on motor learning and recovery.…”